Endoscopic Approach to the Patient with Motility Disorders of the Bile Duct and Sphincter of Oddi

Gastrointestinal Endoscopy Clinics of North America

Volumn 23, Issue 2, 2013, Pages 405-434

  Leung, Wesley D ^a   Sherman, Stuart ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Manometry; Recurrent pancreatitis; Sphincter of Oddi dysfunction; Sphincteroplasty; Sphincterotomy

Indexed keywords

AMYLASE; BOTULINUM TOXIN; BOTULINUM TOXIN A; NIFEDIPINE; NITRATE; OCTREOTIDE; PLACEBO; SCOPOLAMINE BUTYL BROMIDE; TRIACYLGLYCEROL LIPASE; TRIMEBUTINE; VARDENAFIL;

ABDOMINAL PAIN; ABLATION THERAPY; ABSENTEEISM; AMYLASE BLOOD LEVEL; BALLOON DILATATION; BILIARY STENT; BILIARY TRACT ENDOSCOPY; CHILL; CHOLANGIOGRAPHY; CHOLECYSTECTOMY; CHRONIC PANCREATITIS; COLON; COMPUTER ASSISTED TOMOGRAPHY; DILATATION; DRUG EFFICACY; ELECTROACUPUNCTURE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC THERAPY; ERECTILE DYSFUNCTION; FEVER; GALLBLADDER DYSMOTILITY; GASTROINTESTINAL ENDOSCOPY; GOLD STANDARD; HEALTH CARE UTILIZATION; HEPATOBILIARY SCINTISCANNING; HUMAN; IRRITABLE COLON; JAUNDICE; LIVER FUNCTION TEST; MANOMETRY; MIDDLE AGED; NAUSEA AND VOMITING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS SECRETION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPHINCTEROPLASTY; SPHINCTEROTOMY; TRANSCUTANEOUS NERVE STIMULATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VATER PAPILLA STENOSIS; WORK DISABILITY;

BILE DUCTS; BOTULINUM TOXINS, TYPE A; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DILATATION; HUMANS; MANOMETRY; NEUROMUSCULAR AGENTS; NIFEDIPINE; PANCREATITIS; RECURRENCE; SPHINCTER OF ODDI; SPHINCTER OF ODDI DYSFUNCTION; SPHINCTEROTOMY, ENDOSCOPIC; STENTS; VASODILATOR AGENTS;

EID: 84876498806     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.12.006     Document Type: Review

References (154)

1. Steinberg W.M. Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology 1988, 95:1409-1415.
2. Richards R.D., Yeaton P., Shaffer H.A., et al. Human sphincter of Oddi motility and cholecystokinin response following liver transplantation. Dig Dis Sci 1993, 38:462-468.
3. Becker J.M., Parodi J.M. Basic control mechanisms of sphincter of Oddi motor function. Gastrointest Endosc Clin North Am 1993, 3:41-66.
4. Luman W., Williams A.J., Pryde A., et al. Influence of cholecystectomy on sphincter of Oddi motility. Gut 1997, 41:371-374.
5. Anderson T.M., Pitt H.A., Longmire W.P. Experience with sphincteroplasty and sphincterotomy in pancreatobiliary surgery. Ann Surg 1985, 201:399-406.
6. Kurucsai G., Joo I., Fejes R., et al. Somatosensory hypersensitivity in the referred pain area in patients with chronic biliary pain and a sphincter of Oddi dysfunction: new aspects of an almost forgotten pathogenetic mechanism. Am J Gastroenterol 2008, 103:2717-2725.
7. Chen J.W., Thomas A., Woods C.M., et al. Sphincter of Oddi dysfunction produces acute pancreatitis in the possum. Gut 2000, 47:539.
8. Corazziari E., Shaffer E.A., Hogan W., et al. Functional disorders of the biliary tract and pancreas. Gut 1999, 45:48-54.
9. Misra S., Treanor M.R., Vegunta R.K., et al. Sphincter of Oddi dysfunction in children with recurrent abdominal pain: 5-year follow-up after endoscopic sphincterotomy. J Gastroenterol Hepatol 2007, 22:2246-2250.
10. Drossman D.A., Zhiming L., Andruzzi E., et al. US Householder Survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569-1580.
11. Winstead N.J., Wilcox C.M. Health-related quality of life, somatization, and above in sphincter of Oddi dysfunction. J Clin Gastroenterol 2007, 41:773-776.
12. Eversman D., Fogel E.L., Rusche M., et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc 1999, 50:637-641.
13. Linder J.D., Geels W., Wilcox C.M. Prevalence of sphincter of Oddi dysfunction: can results from specialized centers be generalized?. Dig Dis Sci 2002, 47:2411-2415.
14. Bar-Meir S., Halpern Z., Bardan E., et al. Frequency of papillary dysfunction among cholecystectomized patients. Hepatology 1984, 4:328.
15. Sherman S., Troiano F.P., Hawes R.H., et al. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 1991, 86:586-590.
16. Aymerich R.R., Prakash C., Aliperti G. Sphincter of Oddi manometry: is it necessary to measure both biliary and pancreatic sphincter pressure?. Gastrointest Endosc 2000, 52:183-186.
17. Thune A., Scicchitano J., Roberts-Thompson I., et al. Reproducibility of endoscopic sphincter of Oddi manometry. Dig Dis Sci 1991, 36:1401-1405.
18. Varadarajulu S., Hawes R.H., Cotton P.B. Determination of sphincter of Oddi dysfunction in patients with prior normal manometry. Gastrointest Endosc 2003, 58:341-344.
19. Khashab M.A., Watkins J.L., McHenry L., et al. Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies. Endoscopy 2010, 42:369-374.
20. Lehman G.A., Sherman S. Sphincter of Oddi dysfunction. Int J Pancreatol 1996, 20:11-25.
21. Geenen J.E., Nash J.A. The role of sphincter of Oddi manometry and biliary microscopy in evaluating idiopathic recurrent pancreatitis. Endoscopy 1998, 30:237-241.
22. Behar J., Corazziari E., Guelrud M., et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology 2006, 130:1498-1509.
23. Guelrud M., Mendoza S., Mujica V., et al. Sphincter of Oddi (SO) motor function in patients with symptomatic gallstones. Gastroenterology 1993, 104:A361.
24. Ruffolo T.A., Sherman S., Lehman G.A., et al. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci 1994, 39:289-292.
25. Choudhry U., Ruffolo T., Jamidar P., et al. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc 1993, 39:492-495.
26. Lin O.S., Soetikno R.M., Young H.S. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction. Am J Gastroenterol 1998, 93:1833-1836.
27. Steinberg W.M., Salvato R.F., Toskes P.P. The morphine-prostigmin provocative test: is it useful for making clinical decisions?. Gastroenterology 1980, 78:728-731.
28. Lobo D.N., Takhar A.S., Thaper A., et al. The morphine prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy. Gut 2007, 56:1472-1473.
29. Warshaw A.L., Simeone J., Schapiro R.H., et al. Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation. Am J Surg 1985, 149:65-72.
30. Rosenblatt M.L., Catalano M.F., Alcocer E., et al. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. Gastrointest Endosc 2001, 54:697-704.
31. Catalano M.F., Lahoti S., Alcocer E., et al. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 1998, 48:580-587.
32. Corazziari E. Biliary tract imaging. Curr Gastroenterol Rep 1999, 1:123-131.
33. Dancygier H., Nattermann C. The role of endoscopic ultrasound in biliary tract disease: obstructive jaundice. Endoscopy 1994, 26:800-802.
34. Materne R., van Bees B.E., Gigont S.F., et al. Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopic ultrasonography. Endoscopy 2000, 32:3-9.
35. Gillams A.R., Lees W.R. Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Eur Radiol 2007, 17(11):2984-2990.
36. Pereira S.P., Gillams A., Sgouros S.N., et al. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 2007, 56:809-813.
37. Baillie J., Kimberly J. Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 2007, 56:742-744.
38. Testoni P.A., Mariani A., Curioni S., et al. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes. Gastrointest Endosc 2008, 67(7):1028-1034.
39. Aisen A., Sherman S., Jennings S.G., et al. Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of Oddi dysfunction. Acad Radiol 2008, 15:601-609.
40. Kalloo A.N., Sostre S., Pasricha P.J. The Hopkins scintigraphic score: a non-invasive, highly accurate screening test for SOD. Gastroenterology 1994, 106:A342.
41. Sostre S., Kalloo A.N., Spiegler E.J., et al. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med 1992, 33(6):1216-1222.
42. Corazziari E., Cicala M., Habib F.I., et al. Hepatoduodenal bile transit in cholecystectomized subjects: relationship with sphincter of Oddi dysfunction and diagnostic value. Dig Dis Sci 1994, 39:1985-1993.
43. Peng N.J., Lai K.H., Tsay D.G., et al. Efficacy of quantitative cholescintigraphy in the diagnosis of sphincter of Oddi dysfunction. Nucl Med Commun 1994, 15:899-904.
44. Thomas P.D., Turner J.G., Dobbs B.R., et al. Use of 99m Tc-DISIDA biliary scanning with morphine provocation in the detection of elevated sphincter of Oddi basal pressure. Gut 2000, 46:838-841.
45. Craig A.G., Peter D., Saccone G.T., et al. Scintigraphy versus manometry in patients with suspected biliary sphincter of Oddi dysfunction. Gut 2003, 52:352-357.
46. Pineau B.C., Knapple W.L., Spicer K.M., et al. Cholecystokinin-stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol 2001, 96:3106-3109.
47. Roberts K.J., Ismail A., Coldham C., et al. Long-term symptomatic relief following surgical sphincteroplasty for sphincter of Oddi dysfunction. Dig Surg 2011, 28(4):304-308.
48. Cicala M., Habib F.I., Vavassori P., et al. Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut 2002, 50(5):665-668.
49. Ponchon T., Aucia N., Mitchell R., et al. Biopsies of the ampullary region in patients suspected to have sphincter of Oddi dysfunction. Gastrointest Endosc 1995, 42:296-300.
50. Imler T.D., Sherman S., McHenry L., et al. Low yield of significant findings on endoscopic retrograde cholangiopancreatography in patients with pancreatobiliary pain and no objective findings. Dig Dis Sci 2012, 57(12):3252-3257.
51. Cohen S., Bacon B., Berlin J.A., et al. NIH state-of-the-science conference statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002, 56:803-816.
52. Rolny P., Geenen J.E., Hogan W.J. Post-cholecystectomy patients with "objective signs" of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc 1993, 39(6):778-781.
53. Fogel E.L., Sherman S., Bucksot L., et al. Effects of droperidol on the pancreatic and biliary sphincter. Gastrointest Endosc 2003, 58:488-492.
54. Goff J.S. Effect of propofol on human sphincter of Oddi. Dig Dis Sci 1995, 40:2364-2367.
55. Varadarajulu S., Tamhane A., Wilcox C.M. Prospective evaluation of adjunctive ketamine on sphincter of Oddi motility in humans. J Gastroenterol Hepatol 2008, 23:e405-e409.
56. Sherman S., Gottlieb K., Uzer M.F., et al. Effects of meperidine on the pancreatic and biliary sphincter. Gastrointest Endosc 1996, 44:239-242.
57. Blaut U., Alazmi W., Sherman S., et al. The influence of variable-stiffness guide wires on basal biliary sphincter of Oddi pressure measured at endoscopic retrograde cholangiopancreatography. Endoscopy 2010, 42(5):375-380.
58. Craig A.G., Omari T., Lingenfelser T., et al. Development of a sleeve sensor for measurement of sphincter of Oddi motility. Endoscopy 2001, 33:651-657.
59. Blaut U., Sherman S., Fogel E., et al. Influence of cholangiography on biliary sphincter of Oddi manometric parameters. Gastrointest Endosc 2000, 52:624-629.
60. Rolny P., Arleback A., Funch-Jensen P., et al. Clinical significance of manometric assessment of both pancreatic duct and bile duct sphincter in the same patient. Scand J Gastroenterol 1989, 24:751-754.
61. Silverman W.B., Ruffolo T.A., Sherman S., et al. Correlation of basal sphincter pressures measured from both the bile duct and pancreatic duct in patients with suspected sphincter of Oddi dysfunction. Gastrointest Endosc 1992, 38:440-443.
62. Raddawi H.M., Geenen J.E., Hogan W.J., et al. Pressure measurements from biliary and pancreatic segments of sphincter of Oddi: comparison between patients with functional abdominal pain, biliary, or pancreatic disease. Dig Dis Sci 1991, 36:71-74.
63. Hogan W., Sherman S., Pasricha P., et al. Position paper on sphincter of Oddi manometry. Gastrointest Endosc 1997, 45:342-348.
64. Kalloo A.N., Tietjen T.G., Pasricha P.J. Does intrabiliary pressure predict basal sphincter of Oddi pressure? A study in patients with and without gallbladders. Gastrointest Endosc 1996, 44:696-699.
65. Fazel A., Geenen J.E., MoezArdalan K., et al. Intrapancreatic ductal pressure in sphincter of Oddi dysfunction. Pancreas 2005, 30:359-362.
66. Guelrud M., Mendoza S., Rossiter G., et al. Sphincter of Oddi manometry in healthy volunteers. Dig Dis Sci 1990, 35:38-46.
67. McLoughlin M.T., Mitchell R.M. Sphincter of Oddi dysfunction and pancreatitis. World J Gastroenterol 2007, 13:6333-6343.
68. Rolny P., Anderberg B., Ihse I., et al. Pancreatitis after sphincter of Oddi manometry. Gut 1990, 31:821-824.
69. Wehrmann T., Stergiou N., Riphaus A., et al. Correlation between sphincter of Oddi manometry and intraductal ultrasound morphology in patients with suspected sphincter of Oddi dysfunction. Endoscopy 2001, 33:773-777.
70. Madura J.A., Madura J.A., Sherman S., et al. Surgical sphincteroplasty in 446 patients. Arch Surg 2005, 140:504-513.
71. Morgan K.A., Romagnuolo J., Adams D.B. Transduodenal sphincteroplasty in the management of sphincter of Oddi dysfunction and pancreas divisum in the modern era. J Am Coll Surg 2008, 206:908-914.
72. Sherman S. What is the role of ERCP in the setting of abdominal pain of pancreatic or biliary origin (suspected sphincter of Oddi dysfunction)?. Gastrointest Endosc 2002, 56(Suppl):258-266.
73. Thatcher B.S., Snak M.V., Tedesco F.J., et al. Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi. Gastrointest Endosc 1987, 33:91-95.
74. Sherman S., Troiano F.P., Hawes R.H., et al. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with the use of a modified aspirating catheter. Gastrointest Endosc 1990, 36:462-466.
75. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). N Engl J Med 2012, 366(15):1414-1422.
76. Wehrmann T., Stergiou N., Schmitt T., et al. Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with perfusion manometry technique. Endoscopy 2003, 35:472-477.
77. Kawamoto M., Geenen J., Omari T., et al. Sleeve sphincter of Oddi (SO) manometry: a new method for characterizing the motility of the sphincter of Oddi. J Hepatobiliary Pancreat Surg 2008, 15:391-396.
78. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998, 115:1518-1524.
79. Itoh A., Tsukamoto Y., Naitoh Y., et al. Intraductal ultrasonography for the examination of duodenal papillary region. J Ultrasound Med 1994, 13:679-684.
80. Cheon Y.K., Cho Y.D., Moon J.H., et al. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. Gastrointest Endosc 2009, 69:1111-1116.
81. Affronti J. Levitra for sphincter of Oddi dysfunction? Are you kidding?. Gastrointest Endosc 2009, 69:1117-1119.
82. Guelrud M., Mendoza S., Rossiter G., et al. Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 1988, 95:1050-1055.
83. Khuroo M.S., Zargar S.A., Yattoo G.N. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. Br J Clin Pharmacol 1992, 33:477-485.
84. Sand J., Nordback I., Koskinen M., et al. Nifedipine for suspected type II sphincter of Oddi dyskinesia. Am J Gastroenterol 1993, 88:530-535.
85. Vitton V., Delpy R., Gasmi M., et al. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction?. Eur J Gastroenterol Hepatol 2008, 20:15-21.
86. Craig A.G., Toouli J. Slow release nifedipine for patients with sphincter of Oddi dysfunction: results of a pilot study. Intern Med J 2002, 32:119-120.
87. Kalaitzakis E., Ambrose T., Phillips-Hughes J., et al. Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry. BMC Gastroenterol 2010, 10:124.
88. Guelrud M., Rossiter A., Souney P., et al. The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia. Am J Gastroenterol 1991, 86:581-585.
89. Lee S.K., Kim M.H., Kim H.J., et al. Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc 2001, 53:211-216.
90. Moody F.G., Vecchio R., Calabuig R., et al. Transduodenal sphincteroplasty with transampullary septectomy for stenosing papillitis. Am J Surg 1991, 161:213-218.
91. Sherman S., Hawes R.H., Madura J., et al. Comparison of intraoperative and endoscopic manometry of the sphincter of Oddi. Surg Gynecol Obstet 1992, 175:410-418.
92. Boender J., VanBlankenstein M., Nix G.A., et al. Endoscopic papillotomy in biliary tract pain and fluctuating cholestasis with common bile duct dilation and small gallbladder stones. Endoscopy 1992, 24:203-207.
93. Elmi F., Silverman W.B. Biliary sphincter of Oddi dysfunction type I versus occult biliary microlithiasis in post-cholecystectomy patients: are they both part of the same clinical entity?. Dig Dis Sci 2010, 55:842-846.
94. Sgouros S.N., Pereira S.P. Systematic review: sphincter of Oddi dysfunction-non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. Aliment Pharmacol Ther 2006, 24:237-246.
95. Geenen J.E., Hogan W.J., Dodds W.J., et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989, 320:82-87.
96. Toouli J., Roberts-Thomson I., Kellow J., et al. Prospective randomized trial of endoscopic sphincterotomy for treatment of sphincter of Oddi dysfunction. J Gastroenterol Hepatol 1996, 11:A115.
97. Toouli J., Roberts-Thomson I.C., Kellow J., et al. Manometry based randomized trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 2000, 46:98-102.
98. Sherman S., Lehman G.A., Jamidar P., et al. Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD): randomized, controlled study. Gastrointest Endosc 1994, 40:A125.
99. Park S.H., Watkins J.L., Fogel E.L., et al. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc 2003, 57:483-491.
100. Freeman M.L., Gill M., Overby C., et al. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of Oddi dysfunction. J Clin Gastroenterol 2007, 41:94-102.
101. Petersen B.T. An evidence-based review of sphincter of Oddi dysfunction, part I: presentations with "objective" biliary findings (types I and II). Gastrointest Endosc 2004, 59:525-534.
102. Petersen B.T. Sphincter of Oddi dysfunction, part 2: evidence-based review of the presentations, with "objective" pancreatic findings (types I and II) and of presumptive type III. Gastrointest Endosc 2004, 59:670-687. [review].
103. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006, 101:139-147.
104. Singh P., Gurudu S.R., Davidoff S., et al. Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 2004, 59:499-505.
105. Pasricha P.J., Miskovsky E.P., Kalloo A.N. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994, 35:1319-1321.
106. Wehrmann T., Seifert H., Seipp M., et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998, 30(8):702-707.
107. Kozarek R.A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990, 36:93-95.
108. Smith M.T., Sherman S., Ikenberry S., et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic duct stenting. Gastrointest Endosc 1996, 44:268-275.
109. Goff J.S. Common bile duct sphincter of Oddi stenting in patients with suspected sphincter of Oddi dysfunction. Am J Gastroenterol 1995, 90:586-589.
110. Rolny P. Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction. Eur J Gastroenterol Hepatol 1997, 9:467-471.
111. Kozarek R.A. Balloon dilation of the sphincter of Oddi. Endoscopy 1988, 20:207-210.
112. Heinerman P.M., Graf A.H., Boeckl O. Does endoscopic sphincterotomy destroy the function of Oddi's sphincter?. Arch Surg 1994, 129:876-880.
113. Manoukian A.V., Schmalz M.J., Geenen J.E., et al. The incidence of postsphincterotomy stenosis in group II patients with sphincter of Oddi dysfunction. Gastrointest Endosc 1993, 39:496-498.
114. Tarnasky P.R., Hoffman B., Aabakken L., et al. Sphincter of Oddi dysfunction is associated with chronic pancreatitis. Am J Gastroenterol 1997, 92:1125-1129.
115. Gregg J.A. The intraductal secretin test (IDST)-an adjunct to the diagnosis of pancreatic disease and pancreatic physiology. Gastroenterologic endoscopy 1987, 794-807. Saunders, Philadelphia. M.V. Sivak (Ed.).
116. Wiersema M.J., Hawes R.H., Lehman G.A., et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993, 25:555-564.
117. Gottlieb K., Nowak T., Sherman S., et al. Sphincter of Oddi dysfunction (SOD) and abnormal small bowel motility: analysis of 32 patients. Gastrointest Endosc 1994, 40:A109.
118. Evans P.R., Bak Y.T., Dowsett J.F., et al. Small bowel motor dysfunction occurs in patients with biliary dyskinesia. Gastroenterology 1994, 106:A496.
119. Koussayer T., Ducker T.E., Clench M.H., et al. Ampulla of Vater/duodenal wall spasm diagnosed by antroduodenal manometry. Dig Dis Sci 1995, 40:1710-1719.
120. Soffer E.E., Johlin F.L. Intestinal dysmotility in patients with sphincter of Oddi dysfunction: a reason for failed response to sphincterotomy. Dig Dis Sci 1994, 39:1942-1946.
121. DeSautels S.G., Slivka A., Hutson W.R., et al. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology 1999, 116:900-905.
122. Chun A., Desautels S., Slivka A., et al. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of Oddi dysfunction, type III. Dig Dis Sci 1999, 44:631-636.
123. Abraham H.D., Anderson C., Lee D. Somatization disorder in sphincter of Oddi dysfunction. Psychosom Med 1997, 59:553-557.
124. Evans P.R., Dowsett J.F., Kak Y.T., et al. Abnormal sphincter of Oddi response to cholecystokinin in post-cholecystectomy syndrome patients with irritable bowel syndrome: the "irritable sphincter". Dig Dis Sci 1995, 40:1149-1156.
125. Wald A. Functional biliary-type pain: update and controversies. J Clin Gastroenterol 2005, 39:S217-S222.
126. Chen J.W., Saccone G.T., Toouli J. Sphincter of Oddi dysfunction and acute pancreatitis. Gut 1998, 43:305-308.
127. Kuo W.H., Pasricha P.J., Kalloo A.N. The role of sphincter of Oddi manometry in the diagnosis and therapy of pancreatic disease. Gastrointest Endosc Clin North Am 1998, 8:79-85.
128. Choudari C.P., Fogel E.L., Sherman S., et al. Idiopathic pancreatitis: yield of ERCP correlated with patient age. Am J Gastroenterol 1998, 93:1654A.
129. Venu R.P., Geenen J.E., Hogan W., et al. Idiopathic recurrent pancreatitis: an approach to diagnosis and treatment. Dig Dis Sci 1989, 34:56-60.
130. Toouli J., Roberts-Thomson I.C., Dent J., et al. Sphincter of Oddi motility disorders in patients with idiopathic recurrent pancreatitis. Br J Surg 1985, 72:859-863.
131. Guelrud M., Mendoz S., Viera L. Idiopathic recurrent pancreatitis and hypercontractile sphincter of Oddi: treatment with endoscopic sphincterotomy and pancreatic duct dilation. Gastroenterology 1986, 90:1443. [abstract].
132. Gregg J.A. Function and dysfunction of the sphincter of Oddi. ERCP: diagnostic and therapeutic applications 1989, 137-170. Elsevier, New York. I.M. Jacobson (Ed.).
133. Sherman S., Jamidar P., Reber H. Idiopathic acute pancreatitis (IAP): endoscopic diagnosis and therapy. Am J Gastroenterol 1993, 88:1541A.
134. Kaw M., Brodmerkel G.J. ERCP, biliary crystal analysis, and sphincter of Oddi manometry in idiopathic pancreatitis. Gastrointest Endosc 2002, 55:157-162.
135. Coyle W.J., Pineau B.C., Tarnasky P.R., et al. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry, and endoscopic ultrasound. Endoscopy 2002, 34:617-623.
136. Fischer M., Hassan A., Sipe B.W., et al. Endoscopic retrograde cholangiopancreatography and manometry findings in 1,241 idiopathic pancreatitis patients. Pancreatology 2010, 10:444-452.
137. Tarnasky P.R., Hawes R.H. Endoscopic diagnosis and therapy of unexplained (idiopathic) acute pancreatitis. Gastrointest Endosc Clin North Am 1998, 8:13-37.
138. Ros E., Navarro S., Bru C., et al. Occult microlithiasis in "idiopathic" acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991, 101:1701-1709.
139. Elta G.H. Sphincter of Oddi dysfunction and bile duct microlithiasis in acute idiopathic pancreatitis. World J Gastroenterol 2008, 14:1023-1026.
140. Lans J.L., Parikh N.P., Geenen J.E. Applications of sphincter of Oddi manometry in routine clinical investigations. Endoscopy 1991, 23:139-143.
141. Guelrud M., Plaz J., Mendoza S., et al. Endoscopic treatment in Type II pancreatic sphincter dysfunction. Gastrointest Endosc 1995, 41:A398.
142. Wehrmann T. Long-term results (≥ 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis. Endoscopy 2011, 43(3):202-207.
143. Toouli J., Francesco V., Saccone G., et al. Division of sphincter of Oddi for treatment of dysfunction associated with recurrent pancreatitis. Br J Surg 1996, 83:1205-1210.
144. Okolo P.I., Pasricha P.J., Kalloo A.N. What are the long-term results of endoscopic pancreatic sphincterotomy. Gastrointest Endosc 2000, 52:15-19.
145. Jacob L., Geenen J.E., Catalano M.F., et al. Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents. Endoscopy 2001, 33:559-562.
146. Testoni P.A., Caporuscio S., Bagnolo F., et al. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Am J Gastroenterol 2000, 95:1702-1707.
147. Wehrmann T., Schmitt T.H., Arndt A., et al. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. Aliment Pharmacol Ther 2000, 14:1469-1477.
148. Steinberg W.M. Controversies in clinical pancreatology: should the sphincter of Oddi be measured in patients with idiopathic recurrent acute pancreatitis, and should sphincterotomy be performed if the pressure is high?. Pancreas 2003, 27(2):118-121.
149. Tan D., Sherman S. After all these years of SOD and endotherapy-how far have we come? The role of endoscopic treatment for acute recurrent pancreatitis (ARP) with sphincter of Oddi dysfunction (SOD). Endoscopy 2011, 43(3):230-232.
150. Mark D.H., Lefevre F., Flamm C.R., et al. Evidence-based assessment of ERCP in the treatment of pancreatitis. Gastrointest Endosc 2002, 56(Suppl 6):S249-S254.
151. Coté G.A., Imperiale T.F., Schmidt S.E., et al. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology 2012, 143(6):1502-1509.
152. Botoman V.A., Kozarek R.A., Novell L.A., et al. Long term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest Endosc 1994, 40:165-170.
153. Bozkurt T., Orth K.H., Butsch B., et al. Long-term clinical outcome of post-cholecystectomy patients with biliary-type pain: Results of manometry, non-invasive techniques and endoscopic sphincterotomy. Eur J Gastroenterol Hepatol 1996, 8:245-249.
154. Wehrmann T., Wiemer K., Lembcke B., et al. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol 1996, 8:251-256.